company background image
BIOV logo

Bio-View TASE:BIOV Stock Report

Last Price

₪0.29

Market Cap

₪38.1m

7D

1.4%

1Y

-20.0%

Updated

25 Apr, 2024

Data

Company Financials

BIOV Stock Overview

Bio-View Ltd develops, manufactures, and markets automated cell imaging and analysis solutions for use in cytology, cytogenetic, and pathology clinical and research laboratories in Israel and internationally.

BIOV fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance1/6
Financial Health6/6
Dividends0/6

Bio-View Ltd Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Bio-View
Historical stock prices
Current Share Price₪0.29
52 Week High₪0.40
52 Week Low₪0.27
Beta0.40
1 Month Change-1.02%
3 Month Change-13.43%
1 Year Change-19.96%
3 Year Change-5.20%
5 Year Change-9.66%
Change since IPO-59.27%

Recent News & Updates

Shareholders Will Probably Not Have Any Issues With Bio-View Ltd's (TLV:BIOV) CEO Compensation

Dec 04
Shareholders Will Probably Not Have Any Issues With Bio-View Ltd's (TLV:BIOV) CEO Compensation

Recent updates

Shareholders Will Probably Not Have Any Issues With Bio-View Ltd's (TLV:BIOV) CEO Compensation

Dec 04
Shareholders Will Probably Not Have Any Issues With Bio-View Ltd's (TLV:BIOV) CEO Compensation

Estimating The Intrinsic Value Of Bio-View Ltd (TLV:BIOV)

Feb 14
Estimating The Intrinsic Value Of Bio-View Ltd (TLV:BIOV)

Does BioView Ltd.'s (TLV:BIOV) Weak Fundamentals Mean That The Market Could Correct Its Share Price?

Jan 20
Does BioView Ltd.'s (TLV:BIOV) Weak Fundamentals Mean That The Market Could Correct Its Share Price?

What BioView Ltd.'s (TLV:BIOV) 35% Share Price Gain Is Not Telling You

Nov 29
What BioView Ltd.'s (TLV:BIOV) 35% Share Price Gain Is Not Telling You

Shareholder Returns

BIOVIL Medical EquipmentIL Market
7D1.4%-0.3%2.9%
1Y-20.0%6.3%10.8%

Return vs Industry: BIOV underperformed the IL Medical Equipment industry which returned 6.3% over the past year.

Return vs Market: BIOV underperformed the IL Market which returned 10.8% over the past year.

Price Volatility

Is BIOV's price volatile compared to industry and market?
BIOV volatility
BIOV Average Weekly Movement4.0%
Medical Equipment Industry Average Movement4.8%
Market Average Movement4.4%
10% most volatile stocks in IL Market8.3%
10% least volatile stocks in IL Market3.1%

Stable Share Price: BIOV has not had significant price volatility in the past 3 months.

Volatility Over Time: BIOV's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
199833Alan Schwebelwww.bioview.com

Bio-View Ltd develops, manufactures, and markets automated cell imaging and analysis solutions for use in cytology, cytogenetic, and pathology clinical and research laboratories in Israel and internationally. The company’s products include Accord, a workbench microscope station for semi-automated fluorescent imaging and analysis; Accord Plus, an automatic fluorescent imaging system that automatically scans, analyses, and sorts a range of FISH and Karyotype samples in real-time; and Allegro Plus, an automatic imaging system, which identifies various chromosomal aberrations under fluorescent light, such as amplifications, translocations, inversions, and deletions. It also offers DUET-3, an automated imaging system that supports multiple applications; Encore, an automated barcode reader, which enables scanning of various test types in a single scan batch; DeNovo, an automated scanning system for detection, analysis, and characterization of circulating tumor cells from peripheral blood; Solo Workstation, an offline workstation that streamlines and enables review and analysis of test results away from the microscope; Solo Touch Workstation, a stand-alone workstation that streamlines review and analysis of test results away from the microscope; and SoloWeb, a Web-based solution that provides analysis, reporting, and consulting on BioView-scanned cases.

Bio-View Ltd Fundamentals Summary

How do Bio-View's earnings and revenue compare to its market cap?
BIOV fundamental statistics
Market cap₪38.13m
Earnings (TTM)₪383.00k
Revenue (TTM)₪34.77m

99.6x

P/E Ratio

1.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BIOV income statement (TTM)
Revenue₪34.77m
Cost of Revenue₪13.39m
Gross Profit₪21.38m
Other Expenses₪20.99m
Earnings₪383.00k

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)0.0029
Gross Margin61.48%
Net Profit Margin1.10%
Debt/Equity Ratio0%

How did BIOV perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.